Prevail Therapeutics Inc (PRVL) Stock Price, Quote, News and Overview
NASDAQ:PRVL - Nasdaq -
PRVL Quote, Performance and Key Statistics
23
-0.02 (-0.09%)
The current stock price of PRVL is 23 null. In the past month the price decreased by -0.39%. In the past year, price increased by 26.93%.
About PRVL
Company Profile
Prevail Therapeutics Inc. is a gene therapy company. It focuses on developing and commercializing disease-modifying AAV-based gene therapies for patients with devastating neurodegenerative diseases. The company's product candidate consists of PR001, PR006 and PR004 which are in clinical stage. Prevail Therapeutics Inc. is based in New York.
Company Info
Prevail Therapeutics Inc
430 East 29th Street Suite 1520
New York NY 10016
CEO: Asa Abeliovich
Phone: 917-336-9310
Prevail Therapeutics Inc / PRVL FAQ
What is the stock price of Prevail Therapeutics Inc today?
The current stock price of PRVL is 23 null. The price decreased by -0.09% in the last trading session.
What is the ticker symbol for Prevail Therapeutics Inc stock?
The exchange symbol of Prevail Therapeutics Inc is PRVL and it is listed on the Nasdaq exchange.
On which exchange is PRVL stock listed?
PRVL stock is listed on the Nasdaq exchange.
What is Prevail Therapeutics Inc worth?
Prevail Therapeutics Inc (PRVL) has a market capitalization of 787.66M null. This makes PRVL a Small Cap stock.
What are the support and resistance levels for Prevail Therapeutics Inc (PRVL) stock?
Prevail Therapeutics Inc (PRVL) has a support level at 22.98 and a resistance level at 23.03. Check the full technical report for a detailed analysis of PRVL support and resistance levels.
Should I buy Prevail Therapeutics Inc (PRVL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PRVL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PRVL, evaluating the profitability, health, valuation and growth aspects
- Prevail Therapeutics Inc (PRVL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Prevail Therapeutics Inc (PRVL) Sales and EPS estimates to see what analysts future expectations are.
- Prevail Therapeutics Inc (PRVL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Prevail Therapeutics Inc (PRVL) Insider and Institutional Ownership to learn about the owners and their transactions.
- Prevail Therapeutics Inc (PRVL) Stock Chart to make your own analysis
- Prevail Therapeutics Inc (PRVL) Latest news and press-releases to stay up to date.
Does Prevail Therapeutics Inc (PRVL) stock pay dividends?
PRVL does not pay a dividend.
What is the Price/Earnings (PE) ratio of Prevail Therapeutics Inc (PRVL)?
Prevail Therapeutics Inc (PRVL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.3).
PRVL Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to PRVL. When comparing the yearly performance of all stocks, PRVL is one of the better performing stocks in the market, outperforming 88.83% of all stocks.
PRVL Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PRVL. PRVL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
PRVL Financial Highlights
Over the last trailing twelve months PRVL reported a non-GAAP Earnings per Share(EPS) of -2.3. The EPS increased by 40.23% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -57.49% | ||
| ROE | N/A | ||
| Debt/Equity | 0.08 |
PRVL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 73% to PRVL. The Buy consensus is the average rating of analysts ratings from 9 analysts.